Presidio Pharmaceuticals Receives $6,000,000 New Financing

  • Feed Type
  • Date
    12/21/2011
  • Company Name
    Presidio Pharmaceuticals
  • Mailing Address
    1700 Owens Street San Francisco, CA 94158
  • Company Description
    Presidio is focused on developing novel and established therapeutic modalities and small molecule compounds for the treatment of HIV-1, HCV and other chronic virus infections.
  • Website
    http://www.presidiopharma.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $6,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.